OverviewSuggest Edit

Integra LifeSciences is an integrated medical device company providing solutions used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Its products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. The company serves hospitals, surgery centers, and alternate care sites, including physician and dental offices.
TypePublic
HQPrinceton, NJ, US
Websiteintegralife.com
Employee Ratings3.4
Overall CultureC

Latest Updates

Employees (est.) (Dec 2019)4,000(-11%)
Job Openings159
Revenue (FY, 2020)$1.4 B(-9%)
Share Price (Mar 2021)$68.8(+3%)
Cybersecurity ratingCMore

Key People/Management at Integra LifeSciences

Peter Arduini

Peter Arduini

President & Chief Executive Officer
Kenneth Burhop

Kenneth Burhop

Corporate Vice President, Chief Scientific Officer
Andrea Caruso

Andrea Caruso

Corporate Vice President, Business Development
Glenn G. Coleman

Glenn G. Coleman

Executive Vice President & Chief Operating Officer
William Compton

William Compton

Corporate Vice President & Chief Information Officer
Carrie Anderson

Carrie Anderson

Executive Vice President & Chief Financial Officer
Show more

Integra LifeSciences Office Locations

Integra LifeSciences has offices in Princeton, Memphis, Clayton, Shanghai and in 1 other location
Princeton, NJ, US (HQ)
1100 Campus Rd
Memphis, TN, US
7740 Trinity Rd #107, Cordova
Clayton, AU
3/24-30 Winterton Rd
Shanghai, CN
Unit 307, B Tower, SOHO Fuxing Plaza, Danshui Road, Huangpu District
Minato City, JP
6-chōme-19-33 Akasaka
Show all (5)

Integra LifeSciences Financials and Metrics

Integra LifeSciences Revenue

Embed Graph
View revenue for all periods
Integra LifeSciences's revenue was reported to be $1.37 b in FY, 2020
USD

Revenue (FY, 2020)

1.4b

Gross profit (FY, 2020)

851.0m

Gross profit margin (FY, 2020), %

62%

Net income (FY, 2020)

133.9m

EBIT (FY, 2020)

151.4m

Market capitalization (30-Mar-2021)

5.8b

Closing stock price (30-Mar-2021)

68.8

Cash (31-Dec-2020)

470.2m

EV

6.0b
Integra LifeSciences's current market capitalization is $5.8 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

1.2b1.5b1.5b1.4b

Revenue growth, %

24%3%

Cost of goods sold

435.5m571.5m564.7m520.8m

Gross profit

752.7m900.9m952.9m851.0m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

357.1m366.2m365.9m359.7m383.6m379.1m354.3m258.7m370.2m

Cost of goods sold

144.2m137.6m143.2m128.9m143.7m142.6m133.5m105.5m134.8m

Gross profit

212.9m228.6m222.6m230.8m240.0m236.5m220.8m153.2m235.4m

Gross profit Margin, %

60%62%61%64%63%62%62%59%64%
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

174.9m138.8m198.9m470.2m

Accounts Receivable

251.8m265.7m275.3m225.5m

Prepaid Expenses

99.1m90.2m67.9m69.3m

Inventories

296.3m280.3m316.1m310.1m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

64.7m60.8m50.2m133.9m

Depreciation and Amortization

88.9m110.7m109.5m116.0m

Inventories

99.0k8.3m(43.3m)(48.3m)

Accounts Payable

95.3m3.6m14.7m(57.5m)
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

11.0m22.4m35.7m32.8m62.5m34.9m9.2m8.8m41.1m

Depreciation and Amortization

27.1m54.0m83.1m27.1m54.0m81.6m29.2m58.8m89.9m

Inventories

1.3m(3.6m)(3.4m)(12.0m)(21.6m)(30.6m)(26.2m)(47.0m)(45.5m)

Accounts Payable

3.0m(3.4m)9.4m5.4m16.4m366.0k(40.2m)(88.7m)(67.2m)
USDFY, 2017

Revenue/Employee

270.1k

Debt/Equity

1.9 x

Debt/Assets

0.6 x

Financial Leverage

3.3 x
Show all financial metrics

Integra LifeSciences Revenue Breakdown

Embed Graph

Integra LifeSciences revenue breakdown by business segment: 65.6% from Codman Specialty Surgical and 34.4% from Orthopedics and Tissue Technologies

Integra LifeSciences revenue breakdown by geographic segment: 71.0% from United States, 13.0% from Europe, 10.4% from Asia Pacific and 5.6% from Rest of World

Integra LifeSciences Cybersecurity Score

Cybersecurity ratingPremium dataset

C

70/100

SecurityScorecard logo

Integra LifeSciences Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Integra LifeSciences Online and Social Media Presence

Embed Graph

Integra LifeSciences Company Culture

  • Overall Culture

    C

    66/100

  • CEO Rating

    B+

    75/100

  • Compensation

    A-

    82/100

Learn more on Comparably

Integra LifeSciences News and Updates

Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance

Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full-year ended December 31, 2020, consistent with its preliminary revenue results announced on January 14, 2021

Codman Specialty Surgical Launches New Digital Customer Resource Center

We have continued to expand the resources that are available adding additional content based on feedback from our customers using the sites. The use of the Resource Center continues to grow each month. As of December 10th, there have been over 11,000 views of the various pages by over 5,000 users of…

Integra LifeSciences Completes the Acquisition of ACell, Inc.

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it completed the previously-disclosed acquisition of ACell, Inc

Integra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2020 Revenue Results; Will Host Fourth Quarter Financial Results Conference Call on February 18, 2021

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary fourth quarter and full-year 2020 revenue results

Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a definitive agreement to acquire ACell, Inc. (“ACell”) for an upfront cash payment of $300 million at closing, subject to customary purchase price adjustments, an…

Integra LifeSciences Reports Third Quarter 2020 Financial Results

PRINCETON, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2020.
Show more

Integra LifeSciences Frequently Asked Questions

  • Who are Integra LifeSciences key executives?

    Integra LifeSciences's key executives are Peter Arduini, Kenneth Burhop and Andrea Caruso.

  • How many employees does Integra LifeSciences have?

    Integra LifeSciences has 4,000 employees.

  • What is Integra LifeSciences revenue?

    Latest Integra LifeSciences annual revenue is $1.4 b.

  • What is Integra LifeSciences revenue per employee?

    Latest Integra LifeSciences revenue per employee is $343 k.

  • Who are Integra LifeSciences competitors?

    Competitors of Integra LifeSciences include Cook Medical, Wright Medical and NuVasive.

  • Where is Integra LifeSciences headquarters?

    Integra LifeSciences headquarters is located at 1100 Campus Rd, Princeton.

  • Where are Integra LifeSciences offices?

    Integra LifeSciences has offices in Princeton, Memphis, Clayton, Shanghai and in 1 other location.

  • How many offices does Integra LifeSciences have?

    Integra LifeSciences has 5 offices.